ENTYVIO (vedolizumab) for injection

ENTYVIO is a brand-name prescription drug that’s FDA-approved to treat chronic lymphocytic leukemia (CLL), Relapsed follicular B-cell non-Hodgkin lymphoma, Relapsed small lymphocytic lymphoma (SLL). Brand Name: ENTYVIO (vedolizumab) for injection, for intravenous use Initial U.S. Approval: 2014

ENTYVIO (vedolizumab) for injection Price In India and Overseas
ENTYVIO (vedolizumab) for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient inquires under NPP.

Call / WhatsApp Number
+91 9289711088 (Ms. Laxmi Singh)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ENTYVIO (vedolizumab) for injection

Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc. for the treatment of ulcerative colitis and Crohn's disease.

ENTYVIO is an integrin receptor antagonist indicated in adults for the treatment of:
• moderately to severely active ulcerative colitis.
• moderately to severely active Crohn’s disease.

Vedolizumab has been approved for use in adults with moderate to severe ulcerative colitis or Crohn’s disease having a poor response to tumor necrosis factor (TNF) blockers or corticosteroids, or for those who are steroid-dependent.

Drug (Brand / Generic): ENTYVIO / vedolizumab
Current Indications: Ulcerative colitis and Crohn’s disease, Checkpoint inhibitor colitis
Marketed by:: Takeda Pharmaceuticals U.S.A., Inc.
Approval Date: 2014

Dosage forms and strengths of ENTYVIO (vedolizumab).
For injection: 300 mg vedolizumab in a single-dose vial.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.